DrugPatentWatch Database Preview
« Back to Dashboard
|Title:||Oligosaccharides having anti-Xa activity, pharmaceutical compositions containing them and method of use|
|Abstract:||Oligosaccharides obtainable from heparin including heparinic constituents of molecular weights ranging from 2000 to 50,000. Said fractions have a Yin-Wessler titer and a U.S.P. titer in a ratio of at least 30. They consist of chains constituted by no more than 8 saccharidic moities. They possess a strong antithrombotic activity and are then useful as antithrombotic drugs.|
|Inventor(s):||Lormeau; Jean-Claude (Maromme la Maine, FR), Choay; Jean (Paris, FR), Petitou; Maurice (Paris, FR)|
|Assignee:||Choay S.A. (Paris, FR)|
|Filing Date:||Aug 22, 1983|
|Claims:||1. An oligosaccharide fraction of the heparin chain which oligosaccharide which has improved antithrombotic activity in vivo (as measured by the Yin-Wessler test) higher than that of heparin, which oligosaccharide fraction (1) comprises not more than 8 saccharide units, (2) of which one is an N-sulfate-D-glucosamine unit, (3) has anti-Xa activity (measured by the Yin-Wessler test) at least 10 times that of heparin, (4) specific affinity for AT III, (5) a ratio of Yin-Wessler titer to U.S.P. titer of at least 30 and (6) virtually no anticoagulant activity (as determined by the U.S.P. test) and, the biologically acceptable salts of said oligosaccharide. |
2. A therapeutic antithrombotic composition which has antithrombotic activity (as measured by the Yin-Wessler test) higher than that of heparin which composition comprises a therapeutically acceptable carrier and in a therapeutically effective amount, an oligosaccharide of claim 1.
3. A therapeutic method for controlling thrombosis in a patient which comprises administering to said patient the therapeutic antithrombotic composition of claim 2 and controlling thrombosis.